Form 8-K - Current report:
SEC Accession No. 0001437749-18-003204
Filing Date
2018-02-23
Accepted
2018-02-23 13:13:29
Documents
1
Period of Report
2018-02-20
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K atrn20180223_8k.htm 8-K 24934
  Complete submission text file 0001437749-18-003204.txt   26263
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51353 | Film No.: 18635659
SIC: 7389 Services-Business Services, NEC